Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

8 Pages (Click to Jump) V   1 2 3 4 > » 

seeva222
Posted on: Yesterday, 06:18 PM


Group: Member
Posts: 1,424

That would probably put the adult population at at least 2,500. > $270 AUD

  Forum: By Share Code

seeva222
Posted on: Yesterday, 05:38 PM


Group: Member
Posts: 1,424

4,500 EPP patients in the US? Where did you see that?

  Forum: By Share Code

seeva222
Posted on: Yesterday, 03:05 AM


Group: Member
Posts: 1,424

That graphic looks wrong. 40mm for EPP?
  Forum: By Share Code

seeva222
Posted on: Yesterday, 12:59 AM


Group: Member
Posts: 1,424

If this does show progress for DNA repair what are the market implications?

Does this go to a broad-based market? Or will this just be used in high-risk situations?

Tx
  Forum: By Share Code

seeva222
Posted on: Dec 7 2019, 05:38 AM


Group: Member
Posts: 1,424

I’m going to guess these patents have taken some time away from the team, no?
  Forum: By Share Code

seeva222
Posted on: Dec 6 2019, 09:53 AM


Group: Member
Posts: 1,424

Anti-aging. That sounds like a pretty good market to me. :-)
  Forum: By Share Code

seeva222
Posted on: Dec 6 2019, 02:06 AM


Group: Member
Posts: 1,424

And that’s virtually assured. If they can really prove out DNA repair in short order, then we’ll all be getting implants one day. It would be hard to find a company with this much runway and a cash engine like EPP.

Regardless of competition, the market is, potentially, enormous. Now the company has to transition from scrappy to aggressive, they could use some big company experience.
Some
Big
  Forum: By Share Code

seeva222
Posted on: Dec 5 2019, 11:24 PM


Group: Member
Posts: 1,424

You realize that letting a battle on a message board influence you this much is a bit off, correct? It means nothing
  Forum: By Share Code

seeva222
Posted on: Dec 4 2019, 09:09 AM


Group: Member
Posts: 1,424

Not in the same sense. De-risking before meant keeping the company afloat in order to realize it's potential. No we're talking about "possibly" less potential.... less potential in a 11 figure opportunity is not exactly re-risked.
  Forum: By Share Code

seeva222
Posted on: Dec 4 2019, 04:08 AM


Group: Member
Posts: 1,424

Again, is there a reason you declared SWOT was so useful but left out the S&O parts?

This makes you seem completely disingenious. That's why your credibility is spiraling downward.

Eveyrone's okay with WT, if it comes with balance.

You're rapidly becoming a more bloviated Iggy, with MT whatever as your Cimetide.
  Forum: By Share Code

seeva222
Posted on: Dec 4 2019, 03:16 AM


Group: Member
Posts: 1,424

LH might need to change his handle
It is my viewpoint that the company can easily double in value from this price within one year.
  Forum: By Share Code

seeva222
Posted on: Dec 4 2019, 12:10 AM


Group: Member
Posts: 1,424

Avita, the problem with CUV is that it had a massive price runup before approval. Expecting another runup with minuscule sales and approval for EPP in the US (small market) seemed unlikely.

The real value in this company is in creating a 200-million cash flow while solving bigger market problems.
  Forum: By Share Code

seeva222
Posted on: Dec 3 2019, 12:13 PM


Group: Member
Posts: 1,424

Can someone sum up the CEO letter in a few sentences? Reading anything Clinuvel makes by brain hurt.
  Forum: By Share Code

seeva222
Posted on: Dec 3 2019, 05:38 AM


Group: Member
Posts: 1,424

Tanabe MT-7117 says they have an effective / safe drug. We don't know for sure, but if it is true, then it will devastate the stock.
* This is not a fact. The market is so big and delivery systems so different that it actually could mean very little in the grand scheme. The sky is the limit regardless of MT-7117 unless it completely obviates Scenesse and it's offspring.
  Forum: By Share Code

seeva222
Posted on: Dec 3 2019, 05:01 AM


Group: Member
Posts: 1,424

If they aren't moving heaven and earth to lock down US distribution, they're idiots.
  Forum: By Share Code

seeva222
Posted on: Nov 30 2019, 06:00 AM


Group: Member
Posts: 1,424

Youve gone off your rocker.
  Forum: By Share Code

seeva222
Posted on: Nov 30 2019, 12:35 AM


Group: Member
Posts: 1,424

CUV should be making a land grab in the US right now. They will get a return on every dollar they spend. They have millions in the bank.
  Forum: By Share Code

seeva222
Posted on: Nov 29 2019, 11:46 PM


Group: Member
Posts: 1,424

Yup, “level” headed is in full iggy mode
  Forum: By Share Code

seeva222
Posted on: Nov 29 2019, 10:20 AM


Group: Member
Posts: 1,424

So, he has every reason to want this to tank now
  Forum: By Share Code

seeva222
Posted on: Nov 26 2019, 02:29 PM


Group: Member
Posts: 1,424

Shouldn’t TGA approval be a slam dunk after the EMA and FDA?
  Forum: By Share Code

seeva222
Posted on: Nov 24 2019, 08:22 PM


Group: Member
Posts: 1,424

No ones selling because the drug potential is so high. If management isn’t capable of delivering operating results (its ALWAYS been behind,) that’s a problem you can expect major shareholders to give voice to.

Sell your shares and go home is not an option. Keep your shares and demand MGT starts hitting milestones is what people are committed to.

It’s great we go FDA approval, now CUV needs to become a real company that hits milestones and doesn’t step on its own appendages.

The incestuous weworkesque hiring is a problem.

The OTC lotion with a lizard and the Scenesse name on it is unintentionally hilarious.
  Forum: By Share Code

seeva222
Posted on: Nov 24 2019, 02:05 PM


Group: Member
Posts: 1,424

The problem is that the future now requires execution and operational excellence.

Not kooky wordsmithing of newsletters, putting a logo on a fake otc bottle or high minded thinking. Executing on a 1B TAM is hard work.

Can PW execute? Not sure.
  Forum: By Share Code

seeva222
Posted on: Nov 23 2019, 11:40 PM


Group: Member
Posts: 1,424

No expiry date? These are warrants in perpetuity? Sorry for the novice question.
  Forum: By Share Code

seeva222
Posted on: Nov 22 2019, 11:51 PM


Group: Member
Posts: 1,424

The multiple won’t be based upon EPP alone. EPP revenue alone + current multiple (these other indications are not going away and Vitiligo is a slam dunk). Also, I expect more EPP patients to emerge.
  Forum: By Share Code

seeva222
Posted on: Nov 22 2019, 04:03 AM


Group: Member
Posts: 1,424

The company is now in "prove it" mode. The AGM announcements were important, but they're not going to cause a rush to buy. They will definitely help make the case to long-term instos which take time to get on board. I expect bumps on operational milestones and earnings, but I wouldn;t be surprised at a few months of sideways to down action.
  Forum: By Share Code

seeva222
Posted on: Nov 22 2019, 12:20 AM


Group: Member
Posts: 1,424

They need to get insurance authorization first. Training and tools could also be a factor. I didn’t go to the AGM, I did sleep at a Holiday Inn
  Forum: By Share Code

seeva222
Posted on: Nov 21 2019, 12:50 AM


Group: Member
Posts: 1,424

This is the line that caught my attention. >>>>All providing similar effectiveness

STRATEGY I (B)
Therefore, retreating to the inherent properties of alpha-MSH, the third and last part of CLINUVEL’s main strategy is proving the ability of the amplified alpha-MSH to act as a DNA reparative agent. There is ample evidence provided over the years, and we hold these data which only have significance if and when the FDA would have acknowledged and endorsed the technology. This is now a fact.
What does this mean?
On the right-hand side, one sees CLINUVEL’s pipeline of products, derivatives of SCENESSE®, all providing similar effectiveness as the mother technology or molecule, but to be used by us in different formulations and applications, the next generation of our products with a similar expected safety profile.
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 11:07 PM


Group: Member
Posts: 1,424

The performance rights, especially the recession gift (my Mom could hit that target), are tough to swallow.

That’s said, they outed SKIN REPAIR as a goal along with protection. So, that’s about as big a market as exists anywhere. Tell that analyst whining about the TAM to shove it.

Also, great to see the OTC products in the works, that’s one half of the barbell, the FDA approved science being the other.

Did I read that right? PW said the OTC variants have already shown they’re effective? If so, that is blockbuster news. I guess anyone can make claims, but that would be a doozy.
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 10:06 PM


Group: Member
Posts: 1,424

So, is the 3rd indication S/K?
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 01:18 PM


Group: Member
Posts: 1,424

Did he give a timeline on OTC? The chart shows it at execution phase.
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 01:16 PM


Group: Member
Posts: 1,424

A Canadian Dr was trained to deliver Scenesse. Don’t remember who
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 11:45 AM


Group: Member
Posts: 1,424

Screw the short-term shorters. I’m very pleased so far. Bigger than Botox potential
  Forum: By Share Code

seeva222
Posted on: Nov 20 2019, 01:21 AM


Group: Member
Posts: 1,424

I’m not sure that Wahlgren wants to juice the stock. If you listen to him, again and again he talks about the short-term stock price not being important to him. I think he wants good institutional investors which makes going to the NASDAQ a smart move.
  Forum: By Share Code

seeva222
Posted on: Nov 19 2019, 06:52 AM


Group: Member
Posts: 1,424

Is there really a controversy over his pay package? I expect it to sail through.
  Forum: By Share Code

seeva222
Posted on: Nov 19 2019, 01:19 AM


Group: Member
Posts: 1,424

Has the AGM ever produced anything noteworthy?
  Forum: By Share Code

seeva222
Posted on: Nov 18 2019, 04:02 AM


Group: Member
Posts: 1,424

Also, what’s the TAM for XP, Vitiligo, preventative SC?
  Forum: By Share Code

seeva222
Posted on: Nov 17 2019, 06:47 PM


Group: Member
Posts: 1,424

Find out who the producer is of the segment. CUV should demand an retraction - I would assume 7 could be open to a lawsuit if they defamed CUV and didn’t make it right.

This is the kind of thing that could turn into a PR win if they played this well. They won’t.
  Forum: By Share Code

seeva222
Posted on: Nov 17 2019, 06:20 PM


Group: Member
Posts: 1,424

Have any of you guys contacted the station?
  Forum: By Share Code

seeva222
Posted on: Nov 16 2019, 07:52 AM


Group: Member
Posts: 1,424

Evidence is mounting that they spent more time coming up with values and a logo than they did on the NDA and the business.
  Forum: By Share Code

seeva222
Posted on: Nov 15 2019, 06:58 AM


Group: Member
Posts: 1,424

I called the Charlotte center, they have no idea about commercially available scenesse.

I wonder if the research doctors would also be the drs who deliver the commercial version?

Are all of the subjects currently under compassionate use? If so, they should still be receiving it but this time the bill will go to Insurance, no?
  Forum: By Share Code

seeva222
Posted on: Nov 14 2019, 12:06 PM


Group: Member
Posts: 1,424

Haha. Iggy’s still “thinks” Cimetide (which cures his old farmer EPP and led him to sell @ 3 bucks) will make all this a moot point.

If iggys’s back, there’s a buyer.
  Forum: By Share Code

seeva222
Posted on: Nov 13 2019, 10:10 AM


Group: Member
Posts: 1,424

Melbourne-based Avita making a big move.

AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today an institutional placement of A$120.0 million (Institutional Placement) to fund pipeline development of new indications, including optimizing support for clinical trials and development projects, as well as the Company’s continued U.S. commercial growth strategy.
  Forum: By Share Code

seeva222
Posted on: Nov 13 2019, 01:57 AM


Group: Member
Posts: 1,424

Is anyone else concerned that our CEO lives in Singapore at a time when CUV finally has to get highly operational to expand globally and into new product lines?
  Forum: By Share Code

seeva222
Posted on: Nov 12 2019, 10:11 PM


Group: Member
Posts: 1,424

Avita is trader on the nasdaq and the asx
  Forum: By Share Code

seeva222
Posted on: Nov 12 2019, 12:27 PM


Group: Member
Posts: 1,424

Cimetide already exists. How’s it working for your EPP?
  Forum: By Share Code

seeva222
Posted on: Nov 12 2019, 01:04 AM


Group: Member
Posts: 1,424

FDA approval moved Clinuvel onto the launching pad. Approval with zero restrictions in the US was really the only goal I was interested in. Genie bottle and all that. At any time Clinuvel pleases they can make this available for off-label use. But it will take investors awhile to figure out that this is not about EPP (is that investclinuvel website ever going to get going?), thus I was very skeptical of a huge post-approval move. A cash cow based upon an orphan indication that will be tough to replicate even after the patent runs out with almost no downside risk and unlimited upside potential in an area (photo protection) that will only grow in market size that has a route to Cosmoceuticals... that's a pretty unique place to be.

That said, a CEO living in Singapore talking about M&A, while trying to expand worldwide with a hodgepodge management team worries me a great deal.
  Forum: By Share Code

seeva222
Posted on: Nov 9 2019, 11:14 PM


Group: Member
Posts: 1,424

Odd benchmarks:

Avita Medical was down 25% from its pre approval level 1.38 to 1.03 months after approval. A year later it’s up 9x.
Avita never had the years long pre approval runup CUV did. They were recently added to the ASX200 and Nasdaq.

PFNX did have a cuv- esque runup, then fell from 9.8 to 7.46, upon approval went to 8.62 and has steadily climbed to 10.7.



  Forum: By Share Code

seeva222
Posted on: Nov 9 2019, 09:44 PM


Group: Member
Posts: 1,424

Yeah, he sold at 3, uses cimetide for his non-existent EPP and just bought in at 30 after a 10x increase? If Ignor is back. Someone’s buying.
  Forum: By Share Code

seeva222
Posted on: Nov 9 2019, 04:54 AM


Group: Member
Posts: 1,424

We got approval with limited restrictions or oversight. That’s about as much as we could have hoped for. No mention of off label. That said management is far from transparent.
  Forum: By Share Code

seeva222
Posted on: Nov 9 2019, 12:55 AM


Group: Member
Posts: 1,424

9 Conclusion & Recommendations
Based on the available data a REMS is not necessary to ensure the benefits outweigh the risks. There
are no serious risks associated with afamelanotide treatment, and healthcare providers who treat EPP
are familiar with the importance of regular patient monitoring.
  Forum: By Share Code

seeva222
Posted on: Nov 7 2019, 11:51 AM


Group: Member
Posts: 1,424

So how do they cover borrowed shares without driving the price up?

Can someone explain this in plain English?

  Forum: By Share Code

seeva222
Posted on: Nov 7 2019, 05:54 AM


Group: Member
Posts: 1,424

Homm is right. It is far under valued on EPP alone. That is simply a matter of supply vs demand. It’s not a lack of demand. Add in vitiligo, possible skin cancer prevention and other indications plus OTC....

FDA approval uncorked the genie bottle. The time it takes for the market to realize that is our anxiety.
  Forum: By Share Code

seeva222
Posted on: Nov 5 2019, 01:56 AM


Group: Member
Posts: 1,424

Absolutely. Remember the patient getting the liver transplant?
  Forum: By Share Code

seeva222
Posted on: Oct 31 2019, 03:23 AM


Group: Member
Posts: 1,424

The index is a horrible idea. CUV should outperform the index anyone as CEO.

We can certainly create revenue targets (the govt will still pay) and milestones even in a recession.
  Forum: By Share Code

seeva222
Posted on: Oct 30 2019, 01:34 AM


Group: Member
Posts: 1,424

You sold at $3 and we’re taking cimetide for EPP. If iggys back, someone’s buying.
  Forum: By Share Code

seeva222
Posted on: Oct 24 2019, 05:29 PM


Group: Member
Posts: 1,424

Someone showed their cards
  Forum: By Share Code

seeva222
Posted on: Oct 24 2019, 12:33 AM


Group: Member
Posts: 1,424

You’re way too sensitive for someone who posts as often and as stridently as you.
  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 05:44 PM


Group: Member
Posts: 1,424

Sorry for all the posts (early flight and can’t sleep)

Now, I know what you're probably thinking: "Aren't high-growth stocks the first to be walloped when stock market corrections occur, or when the U.S. economy enters a recession?" And the answer is, usually, "Yes."

But the pharmaceutical industry is a different beast altogether. It doesn't play by the same rules as traditional industries, which makes it particularly appealing if it faces extended downside during a stock market correction or recession.

Because big pharma sells high-margin, exclusive medicines that are protected by patents for a defined period of time, these drugmaking giants are usually able to post healthy profits during stock market corrections and recessions. Pfizer wound up raking in $8.6 billion in net income in 2009, with Bristol-Myers one-upping the pharma kingpin with $10.6 billion in net income. Not to mention, big pharma dividends almost always outpace the average yield of S&P 500 stocks.

https://www.fool.com/investing/2018/12/13/a...ustry-duri.aspx

Top 5 Recession Stocks
Consolidated Edison, Inc.
Becton, Dickinson and Co.
Abbott Laboratories.
Automatic Data Processing, Inc.
Colgate-Palmolive Co.
  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 05:23 PM


Group: Member
Posts: 1,424

Its now FDA approved with almost no restrictions:

The implant has received recognition from Cancer Research UK. They have acknowledged its potential to prevent malignant skin cancer

A statement on the Clinuvel claims: 'To date, Clinuvel has spent over $80 million developing the Scenesse
implant drug product as a therapeutic photoprotective drug for patients who are most at risk from UV and sun exposure.
  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 02:46 PM


Group: Member
Posts: 1,424

And there’s this: https://www.dailymail.co.uk/sciencetech/art...scientists.html
  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 02:33 PM


Group: Member
Posts: 1,424

  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 02:28 PM


Group: Member
Posts: 1,424

News to move on:

Cash receipts
Vitiligo trial
OTC
New Indications
First US distribution
Nasdaq
  Forum: By Share Code

seeva222
Posted on: Oct 22 2019, 09:56 AM


Group: Member
Posts: 1,424

Addendum on M&A: Acquisitions make more sense in a recession where strong balance sheets win and credit tightens. If a recession does hit, stock market valuations will go down, but so will private valuations. Some over leveraged companies will get absolutely hammered. I do respect Walnut’s respect for the balance sheet. Long-term, a recession can be quite a good thing for companies with cash flow and a strong balance sheet. Weeds out the pretenders.
  Forum: By Share Code

seeva222
Posted on: Oct 21 2019, 04:51 AM


Group: Member
Posts: 1,424

Challenge for the group: Can this board create a one page investment case for Clinuvel?

Something we can use to send to potential investors or for other purposes. It looks like levelheaded has done A lot of the work
  Forum: By Share Code

seeva222
Posted on: Oct 21 2019, 01:43 AM


Group: Member
Posts: 1,424

Can not fault the PR, need to get more US press. And I ent to see the word tan in there!
  Forum: By Share Code

seeva222
Posted on: Oct 20 2019, 03:11 AM


Group: Member
Posts: 1,424

Outperforming the biotech index? What a ridiculous target. He should hope for a recession. We could do that without a CEo
  Forum: By Share Code

seeva222
Posted on: Oct 18 2019, 10:52 PM


Group: Member
Posts: 1,424

How do shorters make money on churn? They sell shares to drive the stock down and cover... when? How does that covering not drive the stock up?
  Forum: By Share Code

seeva222
Posted on: Oct 18 2019, 11:08 AM


Group: Member
Posts: 1,424

If he hits those goals the share price will be 3.5 x.
  Forum: By Share Code

seeva222
Posted on: Oct 18 2019, 01:20 AM


Group: Member
Posts: 1,424

Avita had a small spike after FDA approval, then sank and went sideways for 5 months, then spiked 6x in news of commercialization.
  Forum: By Share Code

seeva222
Posted on: Oct 17 2019, 10:57 PM


Group: Member
Posts: 1,424

I expect it to move on any Vitiligo news.
  Forum: By Share Code

seeva222
Posted on: Oct 16 2019, 02:06 AM


Group: Member
Posts: 1,424

I definitely picked up on the theme of photo protection for the entire population.
  Forum: By Share Code

seeva222
Posted on: Oct 15 2019, 11:41 PM


Group: Member
Posts: 1,424

I think it will pop on Vitligo trial news and OTC news. Those two signal long-term superstar status. Oh yeah, and the drug tans you safely and Walnut just said it offers overall protection from UVA and UVB. If that claim is true... we're talking blockbuster.

BTW, what restrictions did the FDA put on Scenesse? I never heard the outcome of that. Anyone with an update? I already called my Dr. to inquire about off-label for vitiligo.

Where's Iggy?
  Forum: By Share Code

seeva222
Posted on: Oct 15 2019, 10:10 PM


Group: Member
Posts: 1,424

Vitiligo news will pop the stock as well. I think people are overlooking the fact that the stock has had an insane runup the last few years. That blunts some of the fda effect. While the future and present are bright, I would think new investors have to do a air amount of homework to buy in at this point.

I believe the pattern is to drift lower from here until new news comes along.

Avita dropped, drifted lower, the. spiked a few months later. FDA is the start.
  Forum: By Share Code

seeva222
Posted on: Oct 15 2019, 03:36 PM


Group: Member
Posts: 1,424

“It gives them an overall protection against radiation, specifically UVA/UVB”
  Forum: By Share Code

seeva222
Posted on: Oct 14 2019, 03:17 PM


Group: Member
Posts: 1,424

Because they short spikes which inevitably run out of gas and in doing so drive the market down until enough buy volume comes back in. At least that’s his I understand it
  Forum: By Share Code

seeva222
Posted on: Oct 13 2019, 09:12 AM


Group: Member
Posts: 1,424

Any idea much are the US and Britain worth in EPP alone?
850 patients?
  Forum: By Share Code

seeva222
Posted on: Oct 11 2019, 03:16 PM


Group: Member
Posts: 1,424

So, huge kudos to Walnut on FDA approval. The genie bottle is opened, BUT what is this stupidity about M&A?????????

- It is biggest destroyer of shareholder value next to negligence
- You will pay too much, period
- Bad M&A is like an aggressive form of cancer
- this company can’t maintain things like geographic offices. How could it ever integrate more than like 4 people?

THERE is NO WAY this company is set up to integrate another company, especially with CEO living in Singapore.

70% of acquisitions fail.

Whoever is floating this air turd in the name of scaling needs to put their balls back in the sack

IF CUV buys a company... and it’s a shit ass stupid idea given their management... it should buy IP or a READIBLY usable marketing channel.
Buying a company because you have dry powder (money) is just dumb.
  Forum: By Share Code

seeva222
Posted on: Oct 10 2019, 09:48 PM


Group: Member
Posts: 1,424

CUV touting “systematic photo-protection from light radiation” - I dig that.

https://www.instagram.com/p/B3Z2LqjDSEx/?ig...d=1ahufmmmzfyt4
  Forum: By Share Code

seeva222
Posted on: Oct 10 2019, 11:21 AM


Group: Member
Posts: 1,424

Speculation on quarterly numbers?
  Forum: By Share Code

seeva222
Posted on: Oct 10 2019, 08:50 AM


Group: Member
Posts: 1,424

YOu regress when you stop jak. Scenesse seems to be semi permanent. I’ve got a script for jak, btw.
  Forum: By Share Code

seeva222
Posted on: Oct 10 2019, 08:38 AM


Group: Member
Posts: 1,424

Doesn’t look like the FDA even requires Drs.
  Forum: By Share Code

seeva222
Posted on: Oct 10 2019, 07:55 AM


Group: Member
Posts: 1,424

Couple of thoughts:

  • CUV is in a weird spot because it’s being valued (PE ratio-wise) on nascent revenue when the long-term play is vitiligo, skin cancer, etc. Even if you use JAK inhibitors for Vitiligo, you still need a scenesse treatment to stop the progression. In a way, I think CUV is being penalized for its early cash flow given the huge markets that lie ahead.
  • That said, you have to ask the question about the timing and the impact of those drivers. When will that potential be recognized, and, against a billion + dollar valuation, what’s the upside? I tend to think you’re looking at an 8 bagger in 5 years. I don’t think people realized how desperate the vitiligo market is for a solution. I can’t believe skin cancer associations aren’t beating down CUV’s door. I would.
  • The really squishy part of this is the OTC play. So many factors here. I love their positioning as a brand and the built in distribution from the Flying Dutchman. You literally can’t pay for the branding they’ll have. I think the potential here for the leader in photoprotective skincare to bring an OTC play to market is... well... unlimited.
  • CNS and cell regeneration are probably too far down the road at this point, but there some value to that.
  • Imagine if you’re a family with a history of skin cancer, you have means and you live down south... would you want to know about this? The dude I met who had 35 skin cancers was amazed something like this existed (this is what happens when you chat at an airport bar.)
  • Imagine if you’re a tired jet-lagged CEO who looks like crap, would a tan help you raise money? An actor get a better look? You feel better about you? (I’m on the injectable research version and my tan is way swarthy)
  • The cash isn’t huge, but we are a cash cow with very little overhead that will grow into a $200 million revenue company on current indications alone.
  • Imagine if I told you could invest in a company that could treat vitiligo, possibly prevent skin cancer, will give you a healthy tan, could have side benefits and was completely derisked? BTW, the realization that slathering sunscreen all over your body is an inherently bad idea is going to be a commone thought soon. (These products typically include a combination of two to six of the following active ingredients: oxybenzone, avobenzone, octisalate, octocrylene, homosalate and octinoxate. Mineral sunscreens use zinc oxide and/or titanium dioxide. A handful of products combine zinc oxide with chemical filters. When the FDA began to consider sunscreen safety, it grandfathered in active ingredients from the late 1970s without reviewing the evidence of their potential hazards.)
  • I haven’t been in as long as most of you, but my thesis was: let’s get this to FDA approval and then the genie will be out of the bottle. A “systematic” solution for Vitiligo (no creams, no forever UVB treatment) + other indications + OTC + long-term blinkingly obvious skin-cancer applicability underpinned by an orphan cash-cow indication could be very attractive to a new investor.


All that said, there are likely other places to get high returns (ReCel (Avita) and Occ.Zx are interesting as well).
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 10:21 AM


Group: Member
Posts: 1,424

Just chatting with a guy who had 35 skin cancers removed. He’s 36.

The guy bathes in sun tan lotion. He knows that’s not good for him.

Think some natural protection could have helped him?

Live the bump in the price, but the real prize is till to come

Investor teleconference today: https://s1.c-conf.com/diamondpass/clinuvel-...173-invite.html
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 08:07 AM


Group: Member
Posts: 1,424

Couldn’t this be a PA?

“Scenesse should be administered by a health care professional who is proficient in the subcutaneous implantation procedure and has completed the applicant-provided training.”
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 05:30 AM


Group: Member
Posts: 1,424

Pretty sure Jon Hamm can afford

https://www.digitalspy.com/showbiz/a272666/...-have-vitiligo/
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 05:30 AM


Group: Member
Posts: 1,424

Up 21% now
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 05:15 AM


Group: Member
Posts: 1,424

“six hours for patients receiving Scenesse and 0.75 hours for patients receiving placebo. “

8x
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 04:09 AM


Group: Member
Posts: 1,424

So, holy crap. If I read this right there are NO off-label restrictions.

For the love of god...

Please help me not pass out.
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 03:53 AM


Group: Member
Posts: 1,424

This is unbelievably important
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 03:52 AM


Group: Member
Posts: 1,424

Monitor the EPP sites if you want to feel good
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 03:49 AM


Group: Member
Posts: 1,424

Picked up 200 at 19.95
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 03:36 AM


Group: Member
Posts: 1,424

I’m first in line!!!!!
  Forum: By Share Code

seeva222
Posted on: Oct 9 2019, 03:27 AM


Group: Member
Posts: 1,424

The FDA approved a tanning drug that will protect the skin, curb aging and likely prevent skin cancer!!!

There, I said it.

Good luck keeping this genie in the bottle
  Forum: By Share Code

seeva222
Posted on: Oct 8 2019, 05:12 PM


Group: Member
Posts: 1,424

The FDA has announced approvals in the middle of the US trading day. There’s no reason for them to hold off as everyone gets the info at the same time.
  Forum: By Share Code

seeva222
Posted on: Oct 7 2019, 10:38 PM


Group: Member
Posts: 1,424

Doesn’t he already have equity payouts aligned to those?
  Forum: By Share Code

seeva222
Posted on: Oct 4 2019, 11:20 PM


Group: Member
Posts: 1,424

Sucker
  Forum: By Share Code

seeva222
Posted on: Sep 25 2019, 08:13 AM


Group: Member
Posts: 1,424

Rabbitrun is first on my list of inglorious bastards
  Forum: By Share Code

seeva222
Posted on: Sep 25 2019, 04:55 AM


Group: Member
Posts: 1,424

To quote inglorious bastards “that’s a bingo”

We’re on the threshold of unleashing a drug with really unlimited potential in both the OTC and pharma markets that has a orphan cash engine that is hugely beneficial to a suffering community.

Short term bumps are actually meaningless. IMO.

I’d love to feel richer of course.
  Forum: By Share Code

seeva222
Posted on: Sep 24 2019, 12:16 AM


Group: Member
Posts: 1,424

Cold water alert.

I'm still not convinced FDA approval will give us all a big bang in the short-term. Avita had a relatively small bump that it gave back. it's big rise started 6 months later as it commercialized.

I hope I'm wrong and eveyrone will retire next month.
  Forum: By Share Code

seeva222
Posted on: Sep 19 2019, 08:36 AM


Group: Member
Posts: 1,424

"Mgmt has struggled launching in EU (co by co pricing) & filing w/ FDA, docs very + on drug. 10/6 will be interesting!"

I agree with CUVs pricing strategy, btw. I think it will pay off.
  Forum: By Share Code

seeva222
Posted on: Sep 19 2019, 08:36 AM


Group: Member
Posts: 1,424

"Mgmt has struggled launching in EU (co by co pricing) & filing w/ FDA, docs very + on drug. 10/6 will be interesting!"

I agree with CUVs pricing strategy, btw. I think it will pay off.
  Forum: By Share Code

seeva222
Posted on: Sep 18 2019, 06:32 AM


Group: Member
Posts: 1,424

It's very likely this trading is completely disconnected to the stock's value. I was just chatting with a guy who plays this game.... it's a game... they don't look at fundamentals, the only look at technicals. They make make money, the're in and then they're out without ever knowing thing 1 or thing 2 about the stock or all of our little fears. We're in a bigger game now, fundamentals win in the end, but not always along the way.

It's a good bet that the drivers of the recent fluctuations don't even know what a PDUFA is. They're in and they're out like a hord of locusts.
  Forum: By Share Code

seeva222
Posted on: Sep 11 2019, 10:11 PM


Group: Member
Posts: 1,424

Send him a love note

http://www.bexleyderm.com/contact.html
  Forum: By Share Code

seeva222
Posted on: Sep 11 2019, 09:19 PM


Group: Member
Posts: 1,424

NEA down 4.21%
CUV down 3.53%
  Forum: By Share Code

seeva222
Posted on: Sep 10 2019, 11:33 AM


Group: Member
Posts: 1,424

NEA is doing the same thing. Both stocks are tracking on the same pattern. I doubt it's CUV specific.
  Forum: By Share Code

seeva222
Posted on: Sep 7 2019, 10:40 AM


Group: Member
Posts: 1,424

I would expect no news is good news
  Forum: By Share Code

seeva222
Posted on: Sep 5 2019, 06:01 AM


Group: Member
Posts: 1,424

it = business model
  Forum: By Share Code

seeva222
Posted on: Sep 5 2019, 05:39 AM


Group: Member
Posts: 1,424

This analysis is shit. That's fine, it's a voting machine in the short-term and a weighing machine in the long-term.

We, and I'm not kidding in the slightest, tell CFOs you have to make it dumb enough for a fifth grader for analysts to get it and I've had many say in return, "nope, dumb enough for a first grader"
  Forum: By Share Code

seeva222
Posted on: Sep 1 2019, 10:39 PM


Group: Member
Posts: 1,424

This strikes me as not unimportant

DECREASED PROTOPORPHYRIN AND LIVER ENZYMES
  Forum: By Share Code

seeva222
Posted on: Aug 31 2019, 03:07 AM


Group: Member
Posts: 1,424

This looks suspiciously like a cosmetics display

https://www.instagram.com/p/B1yvUAMBRKl/?ig...d=15qf213ugxn72
  Forum: By Share Code

seeva222
Posted on: Aug 30 2019, 03:21 AM


Group: Member
Posts: 1,424

significance for the uneducated?
  Forum: By Share Code

seeva222
Posted on: Aug 28 2019, 09:32 AM


Group: Member
Posts: 1,424

The C is so much better
  Forum: By Share Code

seeva222
Posted on: Aug 27 2019, 05:33 AM


Group: Member
Posts: 1,424

Anyone else getting acid reflux as Oct approaches? I was less anxious at $4 for some reason.
  Forum: By Share Code

seeva222
Posted on: Aug 26 2019, 01:40 PM


Group: Member
Posts: 1,424

He’s providing you real intel and his subjective opinion that’s useful, stop being a Wally.
  Forum: By Share Code

seeva222
Posted on: Aug 26 2019, 01:22 PM


Group: Member
Posts: 1,424

Good find. If that’s completed and no Ad Comm, it’s just a matter of labeling and oversight (and Trump not killing the markets )
  Forum: By Share Code

seeva222
Posted on: Aug 25 2019, 10:50 PM


Group: Member
Posts: 1,424

Then why did PW call out the fact that they could still call an AdComm in the newsletter. Confused.
  Forum: By Share Code

seeva222
Posted on: Aug 24 2019, 10:54 PM


Group: Member
Posts: 1,424

So I’m guessing they’re not working in the weekend.
  Forum: By Share Code

seeva222
Posted on: Aug 24 2019, 12:28 AM


Group: Member
Posts: 1,424

We have entered the 45 day window with almost 6% outstanding shorts and less overall liquidity due to the ASX inclusion. Dividend announcement and labeling coming in the next few weeks and traders will re-enter the market after the summer doldrums.

]https://boards.sharecafe.com.au/index.php?act=attach&type=post&id=51690
  Forum: By Share Code

seeva222
Posted on: Aug 22 2019, 03:07 AM


Group: Member
Posts: 1,424

They didn’t announce it six weeks prior to the first PDUFA date. Wouldn’t that time have passed?

“The FDA had previously advised that it does not intend to hold an advisory committee meeting during the scientific review of the SCENESSE® NDA.”
  Forum: By Share Code

seeva222
Posted on: Aug 22 2019, 02:46 AM


Group: Member
Posts: 1,424

I looked at a few more. All were approved.
  Forum: By Share Code

seeva222
Posted on: Aug 21 2019, 04:58 AM


Group: Member
Posts: 1,424

Logically, you wouldn’t think they’d extend a deadline on something they didn’t anticipate approving. Agencies aren’t always logical.
  Forum: By Share Code

seeva222
Posted on: Aug 20 2019, 11:18 PM


Group: Member
Posts: 1,424

I predicted Aug 21 as liftoff date. Hope it holds true
  Forum: By Share Code

seeva222
Posted on: Aug 20 2019, 10:27 AM


Group: Member
Posts: 1,424

Increased IR = Nasdaq
  Forum: By Share Code

seeva222
Posted on: Aug 18 2019, 12:20 AM


Group: Member
Posts: 1,424

My only concern on efficacy is that the EMA used patient voice. I agree it doesn’t look like a hurdle right now.
  Forum: By Share Code

seeva222
Posted on: Aug 17 2019, 06:50 AM


Group: Member
Posts: 1,424

Divergence in approval decisions, type of approval, and approved indication were primarily due to differences in agencies’ conclusions about efficacy based on review of the same data or differing clinical data submitted to support the application.
  Forum: By Share Code

seeva222
Posted on: Aug 16 2019, 02:55 PM


Group: Member
Posts: 1,424

Two questions: When did this start treatment? Is this the one previously announced? Tx
  Forum: By Share Code

seeva222
Posted on: Aug 14 2019, 12:50 PM


Group: Member
Posts: 1,424

One more week by my estimate. 5% shorts is a disproportionately huge amount of the liquid trading volume given how closely this is held.in another week this gets dicey
  Forum: By Share Code

seeva222
Posted on: Aug 14 2019, 02:57 AM


Group: Member
Posts: 1,424

No mention of Tsumoyle
  Forum: By Share Code

seeva222
Posted on: Aug 13 2019, 06:01 AM


Group: Member
Posts: 1,424

Based on some documents that have been revealed by user Johnny H on sharecafe.com.au through a FOIA request, reason for the delay has been some missing documentation of the manufacturing process at Evonik in Birmingham, UK. As they could not provide updated information prior to the original PDUFA deadline, I consider this the probable reason for the delay. While, of course, the FDA decision outcome stays unpredictable, this seems to be fixable quite easily for a professional company as Evonik (OTCPK:EVKIY).
  Forum: By Share Code

seeva222
Posted on: Aug 13 2019, 12:03 AM


Group: Member
Posts: 1,424

This is the kind of PR I like. Penguin weeps
  Forum: By Share Code

seeva222
Posted on: Aug 11 2019, 04:01 AM


Group: Member
Posts: 1,424

Predicting that price ignition starts in 9 days (barring overall decline). Get your bets in
  Forum: By Share Code

seeva222
Posted on: Aug 10 2019, 01:01 AM


Group: Member
Posts: 1,424

Well, they might. looks like the others will make money.
  Forum: By Share Code

seeva222
Posted on: Aug 9 2019, 01:38 AM


Group: Member
Posts: 1,424



https://journals.sagepub.com/doi/10.1177/23...eShareContainer

Abstract
Patient representation during the evaluation of medicines by key decision makers such as regulatory agencies, Health Technology Assessment bodies, and healthcare payers is increasingly considered to add value to the appraisals and empowers patients, which means that they gain a more powerful voice over decisions and actions affecting their own health. As I myself suffer from the ultra-rare condition erythropoietic protoporphyria (EPP), I have participated as a patient expert in several discussions on access to afamelanotide, which currently is the only treatment for EPP and was approved in the European Union (EU) in 2014. As a molecular biologist with a PhD in EPP research, I consider myself having the necessary requirements to meaningfully contribute to such assessments. In this article, I share my personal experiences with regard to the discussions on access in Germany and England at the respective national competent authorities, the Federal Joint Committee, and the National Institute for Health and Care Excellence, respectively. In addition, I discuss the insights of the International Porphyria Patient Network, a group of highly empowered EPP patients effectively supporting national patient communities in their efforts to enable access to the afamelanotide treatment in their countries.
  Forum: By Share Code

seeva222
Posted on: Aug 8 2019, 12:11 AM


Group: Member
Posts: 1,424

ITs down 5%
  Forum: By Share Code

seeva222
Posted on: Aug 4 2019, 02:28 AM


Group: Member
Posts: 1,424

CUV is bring hamstrung by success, IMO. The evaluations are being made on EPP rather than look at EPP as the indication that pads the balance sheet for expansion of indications and expansion into other areas (like topicals/cosmeceuticals).increased dosage could be from 2-3 or 3-4.
  Forum: By Share Code

seeva222
Posted on: Aug 3 2019, 05:25 AM


Group: Member
Posts: 1,424

It took two months to recover last time. August 20th closes that window
  Forum: By Share Code

seeva222
Posted on: Aug 1 2019, 12:59 PM


Group: Member
Posts: 1,424

Uhm. He gave you documents. Nothing to “believe”
  Forum: By Share Code

seeva222
Posted on: Aug 1 2019, 05:20 AM


Group: Member
Posts: 1,424

Hey you dope. He just shared very good news. The holdup is a QC/CMC issue not efficacy or safety. That means is a matter of when not if. You should go open up another credit card and buy more.

For F sake, he went through a lot of trouble and is giving you valuable intel and you’re acting like a Douche.
  Forum: By Share Code

seeva222
Posted on: Aug 1 2019, 01:30 AM


Group: Member
Posts: 1,424

Great to see those margins as we pad a healthy balance sheet. But a $3M increase doesn’t mean much against a mkt value of a billion +
  Forum: By Share Code

seeva222
Posted on: Jul 31 2019, 01:52 AM


Group: Member
Posts: 1,424

The flyer here is that were now getting paid earlier so we could see next quarter’s cash receipts coming this quarter.
  Forum: By Share Code

seeva222
Posted on: Jul 28 2019, 08:43 AM


Group: Member
Posts: 1,424

Can someone summarize?
  Forum: By Share Code

seeva222
Posted on: Jul 28 2019, 07:14 AM


Group: Member
Posts: 1,424

I would have thought we’d drift lower. The fun starts this week. Followed by the 60 day pre pdufa window. Good times.
  Forum: By Share Code

seeva222
Posted on: Jul 26 2019, 12:32 PM


Group: Member
Posts: 1,424

I think the name has Asian significance.

https://finance.yahoo.com/news/85-bn-cosmec...-142900205.html

85 Bn Cosmeceutical Market - Global Growth, Trends and Forecasts 2019-2024 - ResearchAndMarkets.com
Business Wire
Business WireJune 27, 2019, 2:29 PM UTC
DUBLIN--(BUSINESS WIRE)--

The "Cosmeceutical Market - Growth, Trends and Forecasts (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

The global cosmeceuticals market is forecasted to reach USD 85 billion by 2024 growing at a CAGR of 8.81% during the forecast period (2019-2024).


Countries, such as the United States, Canada, United Kingdom, Germany, and other European countries held a prominent share in the global cosmeceuticals market. China, India, and Vietnam present considerable growth opportunities for the market players, primarily due to the growing millennial population.

Furthermore, raising awareness regarding cosmeceutical and cosmetics products, such as anti-aging, sun care, and hair care products, is expected to drive the growth potential in the near future. The introduction of new products with bio-active ingredients play a crucial role in driving the demand for cosmeceutical products across the world, especially in the Asia-Pacific region.

Scope of the Report

The global cosmeceuticals market offers a wide range of products broadly categorised under skin care, hair care, lip care, and oral care. Also, the market covers the products available across distribution channels Supermarket/Hypermarkets, Convenience stores, online stores, speciality stores, others. Moreover, the study provides an analysis of the cosmeceuticals market in the emerging and established markets across the world, including North America, Europe, Asia-Pacific, South America, Middle East & Africa.

Key Market Trends

Growing Ageing Population

Consumers, especially the ageing population, are increasingly looking for methods and products to maintain and improve their appearance to look youthful and beautiful, more so with the rising awareness about anti-ageing products. The middle-aged people are increasingly witnessing ageing anxiety, due to the high prevalence of extrinsic signs of ageing. Anti-ageing skin products are known as cosmeceuticals, as they overlap the distinction between cosmetics and pharmaceuticals. Over the past two decades, declining fertility and mortality rate has resulted in a sustained rise in ageing population across the region, especially in China and Japan. Strong desire among men and women to retain youthful appearances has groomed and nurtured the cosmetic industry across the region.

Asia-Pacific Dominates the Global Cosmeceuticals Market -

Though the term cosmeceuticals' started gaining momentum in China recently, it has now become one of the most preferred product categories in the country. Busier and stressful lifestyles of consumers in the country, as well as worsening environmental conditions, created more concern around skin conditions amid consumers who seek products for skin rejuvenation. This has led to an increase in sales of cosmeceuticals. Moreover, the population of Japan is among the most prolific consumers of cosmetics, placing it among the top five national markets for personal care products. From the viewpoint of not only size but also the trends and market demand, Japan can be regarded as a gateway to other Asian markets. Success in the Japanese market can raise product/brand profile and visibility, particularly in other Asian markets.

Competitive Landscape

The most active companies in the market include key players, such as Procter & Gamble, Unilever, L'Oreal SA, Shiseido Co. Ltd, and The Estee Lauder Companies Inc. L'Oreal SA is one of the most active companies, with numerous brands offering a broad range of cosmeceuticals, across the world. The company has spent considerably on improving quality, product innovation in terms of ingredients, functionality, and packaging. Moreover, these active companies have adopted strategic acquisition as their key strategy, to increase their geographical presence and customer base.

  Forum: By Share Code

seeva222
Posted on: Jul 26 2019, 06:32 AM


Group: Member
Posts: 1,424

Not only that, but of intention to become a skincare company and pending M&A. Big beauty is getting into cosmoceuticals and that market is exploding. CUV is going the other way.

Mr Blijdorp is an international entrepreneur who has helped build privately owned B&S International NV, one of the largest global trading houses, over the past three decades. Mr Blijdorp has led B&S’s growth, with the Dutch group focussed on the wholesale and international trading of luxury and fast moving consumer goods and pharmaceutical products. Formerly B&S’s CEO, Mr Blijdorp now focusses on the group’s development and expansion strategy

n 2014 he was recognised for his expertise in merger and acquisitions and leadership as the Ernst & Young Entrepreneur of the Year in the Netherlands. Since joining CLINUVEL in 2014, Mr Blijdorp has been actively involved in the Group’s long-term strategy for product commercialisation, growth, and development.
  Forum: By Share Code

seeva222
Posted on: Jul 24 2019, 02:32 AM


Group: Member
Posts: 1,424

Yup, I think we jumped the gun.
  Forum: By Share Code

seeva222
Posted on: Jul 24 2019, 12:17 AM


Group: Member
Posts: 1,424

Well done CUV. Centers felt scenesse was a money waste(they weren’t making $) because of the protocols which limited opening of new centers.
  Forum: By Share Code

seeva222
Posted on: Jul 21 2019, 12:54 PM


Group: Member
Posts: 1,424

David John Lewis? Of Tesco?
  Forum: By Share Code

seeva222
Posted on: Jul 18 2019, 11:03 PM


Group: Member
Posts: 1,424

Iggy sold at below 5, fixed his EPP with cimetide and still comes back? Someone is buying
  Forum: By Share Code

seeva222
Posted on: Jul 17 2019, 12:34 AM


Group: Member
Posts: 1,424

Thanks, I'm interested to see what impact early payments have as both the coming quarters are the largest.
  Forum: By Share Code

seeva222
Posted on: Jul 16 2019, 08:57 AM


Group: Member
Posts: 1,424

Any guesses on receipts with faster payments? We were up 66% this quarter last year. Are there new centres on line?
  Forum: By Share Code

seeva222
Posted on: Jul 15 2019, 02:23 AM


Group: Member
Posts: 1,424

So, theoretically we could just manufacture in Europe and kill the CMC issue?
  Forum: By Share Code

seeva222
Posted on: Jul 14 2019, 10:22 PM


Group: Member
Posts: 1,424

where are they being manufactured for Europe now?
  Forum: By Share Code

seeva222
Posted on: Jul 14 2019, 12:15 AM


Group: Member
Posts: 1,424

+ 45 day run up before PDUFA
  Forum: By Share Code

seeva222
Posted on: Jul 13 2019, 02:41 AM


Group: Member
Posts: 1,424

A few takeaways:
    A new molecular entity complicates the NDA
    Denial would be due to the risk assessment (not the benefit) which would be based upon CMC, post marketing licensing obligations and commitments, product claims,labeling and longer-term use.
    US labeling could include a "black box" warning as opposed to the "black triangle" classification which requires more vigilance and monitoring.
    A 3-month delay is frustrating, but the FDA has not issued an RTF or recommended withdrawal of the NDA... and that warrants cautious optimism.

In sum, the risk around manufacturing, labeling and distribution are behind the hold-up, not drug benefit or drug safety. One could conclude that none of those is a long-term deal-breaker and that the September labeling requirements will tell the story.
  Forum: By Share Code

seeva222
Posted on: Jul 13 2019, 12:58 AM


Group: Member
Posts: 1,424

So, iggy is the dipstick for a shorter? That makes the most sense.
  Forum: By Share Code

seeva222
Posted on: Jul 12 2019, 11:10 PM


Group: Member
Posts: 1,424

And there is less liquidity with fund holders via the ASX
  Forum: By Share Code

seeva222
Posted on: Jul 11 2019, 11:22 AM


Group: Member
Posts: 1,424

Can you translate?
  Forum: By Share Code

seeva222
Posted on: Jul 10 2019, 12:58 PM


Group: Member
Posts: 1,424

Johnny H just wants CUV to be honest with investors, but he has hundreds of thousands of reasons to want the stock to go up wildly.
  Forum: By Share Code

seeva222
Posted on: Jun 25 2019, 04:26 AM


Group: Member
Posts: 1,424

Whenever the ASX effect dies down, I expect us to languish till cash receipts come out.
  Forum: By Share Code

seeva222
Posted on: Jun 22 2019, 07:21 AM


Group: Member
Posts: 1,424

After a 3 month delay
  Forum: By Share Code

seeva222
Posted on: Jun 22 2019, 02:01 AM


Group: Member
Posts: 1,424

There are some problems, including compromised immune system and the fact that the effects do not last. Still, it's promising.
  Forum: By Share Code

seeva222
Posted on: Jun 14 2019, 07:37 AM


Group: Member
Posts: 1,424

Wasn’t the cutoff may31?
  Forum: By Share Code

seeva222
Posted on: Jun 4 2019, 11:48 PM


Group: Member
Posts: 1,424

Looking at the FDA risk benefit criteria: can we assume that because the FDA didn't request an advisory committee that there is an assumed patient benefit?
We know the risk profile (from Dr. Wally) is extremely low.
IF that's the case, then sloppy filing, CMC and post authorization marketing plan seem like the likely culprits for any delay.

The last ones are all fixable. The first two are not.
  Forum: By Share Code

seeva222
Posted on: Jun 4 2019, 02:49 PM


Group: Member
Posts: 1,424

It's going to go up in 11 days upon ASX inclusion
It's likely going to go up with July cash receipts
It's likely going to go up 30 days before the new PDUFA (actually 45)
It will languish in between (sans new info) with the summer doldrums upon us
  Forum: By Share Code

seeva222
Posted on: Jun 4 2019, 02:46 PM


Group: Member
Posts: 1,424

Can we scorecard this?

Benefit

Effectiveness: Pretty good, but with some hard to quantify results.

Risk
Drug Safety: Excellent
Manufacturing Safety: Dodgy (CMC looks like the culprit here)

Risk Mgt
EMA Protocal: Stringent

  Forum: By Share Code

seeva222
Posted on: Jun 4 2019, 12:16 AM


Group: Member
Posts: 1,424

ASX announcement happens on 6/14. Anyone know how we stack up? We should be darn close.

An aside question: If indexes constantly get rid of shitty companies, wouldn't they almost always go up? How do they account for the losers?
  Forum: By Share Code

seeva222
Posted on: Jun 4 2019, 12:09 AM


Group: Member
Posts: 1,424

so, does scenesse help with the production of eumelanin ?
  Forum: By Share Code

seeva222
Posted on: Jun 3 2019, 10:37 PM


Group: Member
Posts: 1,424

I believe the newsletter stated that they haven’t started on the labeling requirements as they were busy with other activities. There was a hope here that the FDA just accepted it as is.
  Forum: By Share Code

seeva222
Posted on: Jun 3 2019, 09:40 PM


Group: Member
Posts: 1,424

1. I told you guys to stop counting your chickens! Lol

2. Anyone want to read these tea leaves?

“It is not unusual to see the FDA extend its own timelines when it finds that it requires more time for review and to arrive at a final benefit-risk assessment,”

“We will continue to work with the FDA to work at all possible hours to assist the FDA staff to reach a positive conclusion on the scientific review of SCENESSE®. We are sympathetic to the finite resources the US FDA currently has and will patiently wait for the communication on labelling and post-marketing commitments by 6 September,” Dr Wright concluded.
  Forum: By Share Code

seeva222
Posted on: May 31 2019, 10:06 PM


Group: Member
Posts: 1,424

Speaking of Walnut. This latest rise pushed him past $100-million.

Where’s Iggy?
  Forum: By Share Code

seeva222
Posted on: May 30 2019, 01:51 AM


Group: Member
Posts: 1,424

Congrats! Great story. I'm a vitiligo investor as well. Mine is progressing to the out of control stage. I'm turning to an AIP diet.

Now you have to share your business!
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 10:35 PM


Group: Member
Posts: 1,424

FDA approval is the first big stepping stone toward other indications. I didn’t get in this for EPP, though it’s a great engine
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 02:02 PM


Group: Member
Posts: 1,424

Anyone know for what period volume is measured here? (Monthly/annually)
https://www.asx.com.au/asx/share-price-rese...atistics/shares

It’s spiked from 130k to 150k?
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 01:55 PM


Group: Member
Posts: 1,424

Stay hungry my friend. You don’t have to chase the dollar, but most people dislike retirement because the brain is programmed to accomplish.

You’re likely going to want to have a vocation of some sort.

Dying to know his many shares you have. Real FU money where you have zero worries is a pretty high number.
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 08:06 AM


Group: Member
Posts: 1,424

Just a reminder that FDA approval lights a pretty big fuse to Vitiligo and other indications
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 03:57 AM


Group: Member
Posts: 1,424

What is the data on early approvals? Ie What % come early? How many days?

Someone had it. Tx
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 02:24 AM


Group: Member
Posts: 1,424

Last time we had these discussions the stock tanked
  Forum: By Share Code

seeva222
Posted on: May 29 2019, 01:08 AM


Group: Member
Posts: 1,424

I remember fretting over $5 prices.
  Forum: By Share Code

seeva222
Posted on: May 27 2019, 07:30 AM


Group: Member
Posts: 1,424

We’re in the double window, < 45 days from PDUFA, < 20 days from ASX 200
  Forum: By Share Code

seeva222
Posted on: May 24 2019, 11:33 PM


Group: Member
Posts: 1,424

AUD. At least mine was.
  Forum: By Share Code

seeva222
Posted on: May 24 2019, 01:19 PM


Group: Member
Posts: 1,424

I'm at $45/$18
  Forum: By Share Code

seeva222
Posted on: May 24 2019, 12:54 PM


Group: Member
Posts: 1,424

Killing time killing poll:

What’s your price prediction for Jul 9th if approved?

What’s your price prediction for Jul 9th if CRL’d?


  Forum: By Share Code

seeva222
Posted on: May 23 2019, 11:06 PM


Group: Member
Posts: 1,424

BTW, what does their 50% liquidity number mean?

52 week average volume moved to 132 from 125 last week.
  Forum: By Share Code

seeva222
Posted on: May 22 2019, 09:12 AM


Group: Member
Posts: 1,424

4 days to buy. Now it gets interesting
  Forum: By Share Code

seeva222
Posted on: May 21 2019, 01:58 PM


Group: Member
Posts: 1,424

Three candlestick moves up (three soldiers) are followed by a 3-5 session head fake down and a hammer back up. This is what Iearned on wiki today.
  Forum: By Share Code

seeva222
Posted on: May 21 2019, 09:57 AM


Group: Member
Posts: 1,424

(That was a Wiggles reference for you Auzzies with kids)
  Forum: By Share Code

seeva222
Posted on: May 21 2019, 04:37 AM


Group: Member
Posts: 1,424

Lachy!
  Forum: By Share Code

seeva222
Posted on: May 21 2019, 03:30 AM


Group: Member
Posts: 1,424

Cuv presenting tomorrow in NYC

https://www.ubs.com/global/en/investment-ba...ence-agenda.pdf
  Forum: By Share Code

seeva222
Posted on: May 20 2019, 11:28 PM


Group: Member
Posts: 1,424

Started strong, ended weak
  Forum: By Share Code

seeva222
Posted on: May 20 2019, 11:44 AM


Group: Member
Posts: 1,424

Strong volume. 60k
  Forum: By Share Code

seeva222
Posted on: May 20 2019, 05:04 AM


Group: Member
Posts: 1,424

This would be crazy if it works: The advantage for sun protection is that the protection provided by melanin is longer lasting. Missing a spot is less of a worry when applying once a day at most, as opposed to multiple times in the sun while at the beach, etc.

I can’t imagine the demand
  Forum: By Share Code

seeva222
Posted on: May 20 2019, 12:56 AM


Group: Member
Posts: 1,424

Agree, the long-term trajectory is set. I’m still very excited about the topicals. I don’t even know how to value it, but the market is ginormous.
  Forum: By Share Code

seeva222
Posted on: May 18 2019, 06:26 AM


Group: Member
Posts: 1,424

For us not in the know
https://www.investopedia.com/articles/activ...-buy-stocks.asp

Three White Soldiers

This pattern is usually observed after a period of downtrend or in price consolidation. It consists of three long white candles that close progressively higher on each subsequent trading day. Each candle opens higher than the previous open and closes near the high of the day, showing a steady advance of buying pressure. Investors should exercise caution when white candles appear to be too long as that may attract short sellers and push the price of the stock further down.

  Forum: By Share Code

seeva222
Posted on: May 17 2019, 11:09 PM


Group: Member
Posts: 1,424

https://www.orthocell.com.au
  Forum: By Share Code

seeva222
Posted on: May 17 2019, 12:03 PM


Group: Member
Posts: 1,424

31.64, you’re getting slow on the draw
  Forum: By Share Code

seeva222
Posted on: May 17 2019, 01:04 AM


Group: Member
Posts: 1,424

chugga, chugga.... and we're still just approaching the lift-off windows for FDA and ASX. The volume (329,856) shouldn't hurt.
  Forum: By Share Code

seeva222
Posted on: May 16 2019, 01:43 AM


Group: Member
Posts: 1,424

Exactly, currently you can do skin grafting, but imagine if you could just "spray on new skin"? This seems like a crazy good medtech breakthrough. They're focused on burn patients right now.

  Forum: By Share Code

seeva222
Posted on: May 16 2019, 01:07 AM


Group: Member
Posts: 1,424

I love their recell technology. Theoretically you could replace your skin in any area you're having a problem.
  Forum: By Share Code

seeva222
Posted on: May 14 2019, 11:00 PM


Group: Member
Posts: 1,424

I wonder if there are laggards ready to be relegated as well.
  Forum: By Share Code

seeva222
Posted on: May 14 2019, 12:32 PM


Group: Member
Posts: 1,424

When is the cutoff for measurement?
  Forum: By Share Code

8 Pages (Click to Jump) V   1 2 3 4 > » 

Cant find what you are looking for? Show all active topics from the last 3 months


New Posts  New Replies
No New Posts  No New Replies
Hot topic  Hot Topic (New)
No new  Hot Topic (No New)



TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING